Your browser doesn't support javascript.
loading
Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients.
Kriegsmann, Katharina; Baertsch, Marc-Andrea; Awwad, Mohamed H S; Merz, Maximilian; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Becker, Natalia; Benner, Axel; Raab, Marc S; Hillengass, Jens; Bertsch, Uta; Dürig, Jan; Salwender, Hans Jürgen; Hänel, Mathias; Fenk, Roland; Munder, Markus; Weisel, Katja; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael.
Afiliação
  • Kriegsmann K; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany. katharina.kriegsmann@med.uni-heidelberg.de.
  • Baertsch MA; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Awwad MHS; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Merz M; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Hose D; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Seckinger A; National Center for Tumor Diseases, University Hospital, Heidelberg, Germany.
  • Jauch A; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Becker N; National Center for Tumor Diseases, University Hospital, Heidelberg, Germany.
  • Benner A; Institute of Human Genetics, University Heidelberg, Heidelberg, Germany.
  • Raab MS; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Hillengass J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Bertsch U; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Dürig J; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Salwender HJ; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Hänel M; National Center for Tumor Diseases, University Hospital, Heidelberg, Germany.
  • Fenk R; Department of Hematology, University Essen, Essen, Germany.
  • Munder M; Asklepios Klinik Hamburg Altona, Hamburg, Germany.
  • Weisel K; Klinikum Chemnitz, Chemnitz, Germany.
  • Müller-Tidow C; Department of Hematology, Oncology and Clinical Immunology, University Düsseldorf, Düsseldorf, Germany.
  • Goldschmidt H; Department of Hematology, Oncology, and Pneumology, University Medicine Mainz, Mainz, Germany.
  • Hundemer M; Department of Hematology, Oncology, Immunology and Rheumatology, University Tübingen, Tübingen, Germany.
Blood Cancer J ; 9(2): 13, 2019 01 29.
Article em En | MEDLINE | ID: mdl-30696815
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poliploidia / Proteínas de Transporte / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poliploidia / Proteínas de Transporte / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2019 Tipo de documento: Article